LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTION
- 1 March 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8639), 640-642
- https://doi.org/10.1016/s0140-6736(89)92144-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugsClinical Pharmacology & Therapeutics, 1988
- HEPATIC TRANSPLANTATION IN EUROPEThe Lancet, 1987
- The 14CO2 breath test: facilities and limitations of a rapid and noninvasive method for in vivo evaluation of modified hepatic cytochrome P-450 ? a critiqueArchives of Toxicology, 1987
- Anaphylactic Reaction to LidocaineJAMA Otolaryngology–Head & Neck Surgery, 1986
- Caffeine: A Model Compound for Measuring Liver FunctionHepatology, 1984
- Determinants of Drug Disposition in Patients with Cirrhosis†Hepatology, 1983
- Drugs as Indicators of Hepatic FunctionHepatology, 1982
- Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.BMJ, 1977
- Assessment of Aminopyrine Metabolism in Man by Breath Analysis after Oral Administration of14C-AminopyrineNew England Journal of Medicine, 1974
- Predictive Value of a Single Diagnostic Test in Unselected PopulationsNew England Journal of Medicine, 1966